Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv Yafo, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Nasus Pharma Ltd has filed 82 SEC EDGAR filings since 30 Aug 2024

SEC filing history

Showing 26-50 of 82 matching filings.

Per page
25
Current page
2
D File 021-574660

D filing

Filing date
25 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
24 Feb 2026
Reporting date
23 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
13 Feb 2026
Reporting date
13 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
12 Feb 2026
Reporting date
11 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
29 Jan 2026
Reporting date
29 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
20 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
22 Dec 2025
Reporting date
22 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
20 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
18 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95201

SCHEDULE 13G filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95201

SCHEDULE 13G filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95201

SCHEDULE 13G filing

Filing date
10 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
03 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
08 Oct 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
30 Sep 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
05 Sep 2025
Reporting date
05 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95201

SCHEDULE 13G filing

Filing date
20 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-42796

6-K

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-288582

424B4

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288582

EFFECT filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-42796

NYSE AMERICAN CERTIFICATION

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .